Large gap with delayed quotes
|
Last quote
08/15/2026
-
02:00:00
|
Bid
08/14/2026 -
21:59:58
|
Bid Volume |
Ask
08/14/2026 -
21:59:58
|
Ask Volume |
|---|---|---|---|---|
|
22.08
+0.09
(
+0.41% )
|
22.08
|
1,300 |
22.09
|
100 |
Analysis date: 14.08.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 22.05.2026.
Interest
Weak
Weak
Two stars since 07.08.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 07.08.2026 at a price of 23.59.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 23.06.2026.
4wk Rel Perf
12.51%
12.51%
The four-week dividend-adjusted overperformance versus SP500 is 12.51%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.91%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 6.24%.
Mkt Cap in $bn
2.50
2.50
With a market capitalization between $2 & $8bn, VIRIDIAN THERAPEUTICS is considered a mid-cap stock.
G/PE Ratio
0.41
0.41
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
-103.64
-103.64
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
42.69%
42.69%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
14
14
Over the last seven weeks, an average of 14 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
20
20
For 1% of index variation, the stock varies on average by 0.20%.
Correlation
0.03
0.03
Stock movements are totally independent of index variations.
Value at Risk
16.11
16.11
The value at risk is estimated at USD 16.11. The risk is therefore 72.98%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.07.2025
15.07.2025